2-24790654-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001013663.2(PTRHD1):c.253-73C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,445,678 control chromosomes in the GnomAD database, including 177,082 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.42 ( 15262 hom., cov: 32)
Exomes 𝑓: 0.50 ( 161820 hom. )
Consequence
PTRHD1
NM_001013663.2 intron
NM_001013663.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.899
Genes affected
PTRHD1 (HGNC:33782): (peptidyl-tRNA hydrolase domain containing 1) This gene encodes the enzyme peptidyl-tRNA hydrolase. Peptidyl-tRNA hydrolases perform the essential function of recycling peptidyl-tRNAs. Mutations in this gene are associated with autosomal-recessive intellectual disability and parkinsonism. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-24790654-G-C is Benign according to our data. Variant chr2-24790654-G-C is described in ClinVar as [Benign]. Clinvar id is 1221296.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTRHD1 | NM_001013663.2 | c.253-73C>G | intron_variant | ENST00000328379.6 | |||
LOC105369164 | XR_939843.4 | n.1636C>G | non_coding_transcript_exon_variant | 3/3 | |||
LOC105369164 | XR_001739341.2 | n.868C>G | non_coding_transcript_exon_variant | 4/4 | |||
LOC105369164 | XR_007086245.1 | n.1420C>G | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTRHD1 | ENST00000328379.6 | c.253-73C>G | intron_variant | 1 | NM_001013663.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.418 AC: 63499AN: 151910Hom.: 15248 Cov.: 32
GnomAD3 genomes
AF:
AC:
63499
AN:
151910
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.498 AC: 644335AN: 1293650Hom.: 161820 AF XY: 0.499 AC XY: 318305AN XY: 638474
GnomAD4 exome
AF:
AC:
644335
AN:
1293650
Hom.:
AF XY:
AC XY:
318305
AN XY:
638474
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.418 AC: 63508AN: 152028Hom.: 15262 Cov.: 32 AF XY: 0.422 AC XY: 31326AN XY: 74280
GnomAD4 genome
AF:
AC:
63508
AN:
152028
Hom.:
Cov.:
32
AF XY:
AC XY:
31326
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1958
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at